Fund profile
Tickers
XBI
Fund manager
Total assets
$7.66 bn
Liabilities
$533.39 mm
Net assets
$7.13 bn
Number of holdings
143.00
XBI stock data
143 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
State Street Navigator Securities Lending Portfolio II | 531.39 mm | 531.39 mm shares | 7.46 | Short-term investment vehicle | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 235.85 mm | 1.49 mm shares | 3.31 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 212.09 mm | 665.79 k shares | 2.98 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 203.98 mm | 839.40 k shares | 2.86 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 202.27 mm | 2.95 mm shares | 2.84 | Common equity | Long | USA |
AMGN Amgen Inc. | 200.65 mm | 642.19 k shares | 2.82 | Common equity | Long | USA |
ABBV AbbVie Inc. | 195.15 mm | 1.14 mm shares | 2.74 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 194.44 mm | 185.00 k shares | 2.73 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 193.50 mm | 4.58 mm shares | 2.72 | Common equity | Long | USA |
BIIB Biogen Inc. | 191.93 mm | 827.92 k shares | 2.69 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 189.10 mm | 2.30 mm shares | 2.65 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 186.99 mm | 398.94 k shares | 2.62 | Common equity | Long | USA |
NTRA Natera, Inc. | 184.11 mm | 1.70 mm shares | 2.58 | Common equity | Long | USA |
VKTX Viking Therapeutics, Inc. | 184.07 mm | 3.47 mm shares | 2.58 | Common equity | Long | USA |
INCY Incyte Corporation | 177.40 mm | 2.93 mm shares | 2.49 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 171.70 mm | 1.25 mm shares | 2.41 | Common equity | Long | USA |
MRNA Moderna, Inc. | 162.67 mm | 1.37 mm shares | 2.28 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 147.03 mm | 2.71 mm shares | 2.06 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 105.91 mm | 982.62 k shares | 1.49 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 105.59 mm | 376.88 k shares | 1.48 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
102.03 mm | 1.89 mm shares | 1.43 | Common equity | Long | Switzerland |
APLS Apellis Pharmaceuticals, Inc. | 96.05 mm | 2.50 mm shares | 1.35 | Common equity | Long | USA |
Roivant Sciences Ltd
|
90.74 mm | 8.58 mm shares | 1.27 | Common equity | Long | Bermuda |
IONS Ionis Pharmaceuticals, Inc. | 83.28 mm | 1.75 mm shares | 1.17 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 81.23 mm | 3.62 mm shares | 1.14 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 79.44 mm | 432.58 k shares | 1.11 | Common equity | Long | USA |
INSM Insmed Incorporated | 77.81 mm | 1.16 mm shares | 1.09 | Common equity | Long | USA |
CERE Cerevel Therapeutics Holdings Inc | 77.55 mm | 1.90 mm shares | 1.09 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 74.55 mm | 1.92 mm shares | 1.05 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 73.97 mm | 979.67 k shares | 1.04 | Common equity | Long | USA |
Alkermes PLC
|
71.94 mm | 2.99 mm shares | 1.01 | Common equity | Long | Ireland |
BBIO BridgeBio Pharma, Inc. | 71.19 mm | 2.81 mm shares | 1.00 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 70.96 mm | 1.36 mm shares | 1.00 | Common equity | Long | USA |
Biohaven Ltd
|
70.27 mm | 2.02 mm shares | 0.99 | Common equity | Long | Virgin Islands (British) |
TGTX TG Therapeutics, Inc. | 62.03 mm | 3.49 mm shares | 0.87 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 60.77 mm | 1.61 mm shares | 0.85 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 55.91 mm | 6.97 mm shares | 0.78 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 53.66 mm | 1.31 mm shares | 0.75 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 53.09 mm | 1.50 mm shares | 0.74 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 52.57 mm | 1.07 mm shares | 0.74 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 51.98 mm | 1.16 mm shares | 0.73 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 51.30 mm | 3.16 mm shares | 0.72 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 50.78 mm | 669.38 k shares | 0.71 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 49.28 mm | 6.65 mm shares | 0.69 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 49.00 mm | 887.79 k shares | 0.69 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 48.30 mm | 2.16 mm shares | 0.68 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 46.88 mm | 4.73 mm shares | 0.66 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 46.21 mm | 1.13 mm shares | 0.65 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 45.76 mm | 1.24 mm shares | 0.64 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 45.59 mm | 1.26 mm shares | 0.64 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 43.65 mm | 1.24 mm shares | 0.61 | Common equity | Long | USA |
GERN Geron Corporation | 42.45 mm | 10.01 mm shares | 0.60 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 40.07 mm | 1.71 mm shares | 0.56 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 39.41 mm | 1.52 mm shares | 0.55 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 38.44 mm | 1.46 mm shares | 0.54 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 37.80 mm | 1.84 mm shares | 0.53 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 36.40 mm | 1.57 mm shares | 0.51 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 36.22 mm | 3.23 mm shares | 0.51 | Common equity | Long | USA |
NVAX Novavax, Inc. | 34.31 mm | 2.71 mm shares | 0.48 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 34.29 mm | 795.17 k shares | 0.48 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 33.49 mm | 799.45 k shares | 0.47 | Common equity | Long | USA |
ADMA ADMA Biologics, Inc. | 32.38 mm | 2.90 mm shares | 0.45 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 31.79 mm | 1.04 mm shares | 0.45 | Common equity | Long | USA |
VCEL Vericel Corporation | 31.39 mm | 684.14 k shares | 0.44 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 30.88 mm | 4.12 mm shares | 0.43 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 30.83 mm | 750.90 k shares | 0.43 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 30.47 mm | 774.33 k shares | 0.43 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 29.78 mm | 4.82 mm shares | 0.42 | Common equity | Long | USA |
CPRX Catalyst Pharmaceuticals, Inc. | 29.73 mm | 1.92 mm shares | 0.42 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 29.65 mm | 1.42 mm shares | 0.42 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 29.38 mm | 1.25 mm shares | 0.41 | Common equity | Long | USA |
IBRX ImmunityBio, Inc. | 28.49 mm | 4.51 mm shares | 0.40 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 28.05 mm | 939.72 k shares | 0.39 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 27.22 mm | 595.54 k shares | 0.38 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 26.99 mm | 778.91 k shares | 0.38 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 26.54 mm | 1.29 mm shares | 0.37 | Common equity | Long | USA |
MORF Morphic Holding, Inc. | 26.29 mm | 771.60 k shares | 0.37 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 26.21 mm | 1.22 mm shares | 0.37 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals, Inc. | 25.93 mm | 3.98 mm shares | 0.36 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 24.97 mm | 2.68 mm shares | 0.35 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 24.69 mm | 1.14 mm shares | 0.35 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 24.36 mm | 712.51 k shares | 0.34 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 23.65 mm | 967.02 k shares | 0.33 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 22.77 mm | 558.17 k shares | 0.32 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 21.34 mm | 1.55 mm shares | 0.30 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 20.75 mm | 988.75 k shares | 0.29 | Common equity | Long | USA |
Prothena Corp PLC
|
20.72 mm | 1.00 mm shares | 0.29 | Common equity | Long | Ireland |
Arcturus Therapeutics Holdings, Inc. | 19.66 mm | 807.25 k shares | 0.28 | Common equity | Long | USA |
VRDN Viridian Therapeutics, Inc. | 19.52 mm | 1.50 mm shares | 0.27 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 19.23 mm | 3.52 mm shares | 0.27 | Common equity | Long | USA |
MNKD MannKind Corporation | 18.93 mm | 3.63 mm shares | 0.27 | Common equity | Long | USA |
CGEM Cullinan Oncology, Inc. | 18.89 mm | 1.08 mm shares | 0.27 | Common equity | Long | USA |
XNCR Xencor, Inc. | 18.71 mm | 988.34 k shares | 0.26 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 17.71 mm | 428.11 k shares | 0.25 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 16.65 mm | 527.47 k shares | 0.23 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 16.32 mm | 694.35 k shares | 0.23 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 16.05 mm | 1.90 mm shares | 0.23 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 15.51 mm | 1.89 mm shares | 0.22 | Common equity | Long | USA |
ALT Altimmune, Inc. | 15.25 mm | 2.29 mm shares | 0.21 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 15.10 mm | 991.21 k shares | 0.21 | Common equity | Long | USA |
IMNM Immunome, Inc. | 14.53 mm | 1.20 mm shares | 0.20 | Common equity | Long | USA |
CDNA CareDx, Inc | 14.37 mm | 925.49 k shares | 0.20 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 13.85 mm | 1.28 mm shares | 0.19 | Common equity | Long | USA |
CDMO Avid Bioservices, Inc. | 13.62 mm | 1.91 mm shares | 0.19 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 13.43 mm | 1.51 mm shares | 0.19 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 13.39 mm | 1.72 mm shares | 0.19 | Common equity | Long | USA |
RLAY Relay Therapeutics, Inc. | 13.08 mm | 2.01 mm shares | 0.18 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 12.88 mm | 514.11 k shares | 0.18 | Common equity | Long | USA |
OCGN Ocugen, Inc. | 12.79 mm | 8.25 mm shares | 0.18 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 12.49 mm | 1.07 mm shares | 0.18 | Common equity | Long | USA |
ETNB 89bio, Inc. | 11.90 mm | 1.49 mm shares | 0.17 | Common equity | Long | USA |
Kiniksa Pharmaceuticals International Plc
|
11.71 mm | 627.09 k shares | 0.16 | Common equity | Long | UK |
SRRK Scholar Rock Holding Corporation | 11.46 mm | 1.38 mm shares | 0.16 | Common equity | Long | USA |
SCLX Scilex Holding Company | 11.46 mm | 5.94 mm shares | 0.16 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals, Inc. | 11.42 mm | 1.06 mm shares | 0.16 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 11.19 mm | 248.22 k shares | 0.16 | Common equity | Long | USA |
STOK Stoke Therapeutics, Inc. | 11.17 mm | 826.78 k shares | 0.16 | Common equity | Long | USA |
CRBP Corbus Pharmaceuticals Holdings, Inc. | 10.87 mm | 240.16 k shares | 0.15 | Common equity | Long | USA |
EDIT Editas Medicine, Inc. | 10.38 mm | 2.22 mm shares | 0.15 | Common equity | Long | USA |
ATXS Astria Therapeutics, Inc. | 10.34 mm | 1.14 mm shares | 0.15 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 10.06 mm | 4.32 mm shares | 0.14 | Common equity | Long | USA |
MDXG MiMedx Group, Inc. | 9.91 mm | 1.43 mm shares | 0.14 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corp. | 9.80 mm | 2.32 mm shares | 0.14 | Common equity | Long | USA |
HRTX Heron Therapeutics, Inc. | 9.33 mm | 2.67 mm shares | 0.13 | Common equity | Long | USA |
CCCC C4 Therapeutics, Inc. | 8.83 mm | 1.91 mm shares | 0.12 | Common equity | Long | USA |
FATE Fate Therapeutics, Inc. | 8.51 mm | 2.60 mm shares | 0.12 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 8.50 mm | 1.20 mm shares | 0.12 | Common equity | Long | USA |
CABA Cabaletta Bio, Inc. | 8.02 mm | 1.07 mm shares | 0.11 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 7.88 mm | 925.72 k shares | 0.11 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 7.50 mm | 1.54 mm shares | 0.11 | Common equity | Long | USA |
VYGR Voyager Therapeutics, Inc. | 7.27 mm | 918.77 k shares | 0.10 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals, Inc. | 7.06 mm | 1.73 mm shares | 0.10 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 6.76 mm | 411.89 k shares | 0.09 | Common equity | Long | USA |
TNGX Tango Therapeutics, Inc. | 6.44 mm | 750.42 k shares | 0.09 | Common equity | Long | USA |
SVRA Savara Inc. | 5.63 mm | 1.40 mm shares | 0.08 | Common equity | Long | USA |
ITOS iTeos Therapeutics, Inc. | 5.50 mm | 370.34 k shares | 0.08 | Common equity | Long | USA |
HUMA Humacyte, Inc. | 5.15 mm | 1.07 mm shares | 0.07 | Common equity | Long | USA |
ALEC Alector, Inc. | 4.70 mm | 1.04 mm shares | 0.07 | Common equity | Long | USA |
State Street Institutional Liquid Reserves Fund | 3.28 mm | 3.28 mm shares | 0.05 | Short-term investment vehicle | Long | USA |
CONTRA INHIBRX INC | 1.07 mm | 1.65 mm shares | 0.02 | Equity derivative | N/A | USA |
CONTRA MIRATI THERAPEU | 958.69 k | 1.37 mm shares | 0.01 | Equity derivative | N/A | USA |
OABI OmniAb, Inc. | 0 | 161.96 k shares | 0.00 | Common equity | Long | USA |
OABI OmniAb, Inc. | 0 | 161.96 k shares | 0.00 | Common equity | Long | USA |